NHS Change Challenge initiatives published

The NHS Change Challenge used crowdsourcing to identify almost 200 initiatives introduced during lockdown which proved beneficial. The project is now working to write these up in more detail so that we can publish them back onto the site for further comments and discussion. Due to the overwhelming responses received, the focus initially is on writing up the highest-scoring ideas based on impact and feasibility within each challenge area. 

The first two ideas have been published on the site. Keep checking for further ideas which will be published over the next few weeks.

Guest blog: the Change Challenge Collaborative

by Greta McLachlan, Fellow at the Strategic planning and development cell, NHS England and Improvement, part of the Change Challenge Collaborative.

The change challenge collaborative is a group of professionals who have come together to work across the MSK, orthopaedic and rheumatology specialties to try and capture beneficial changes that have occurred within the NHS during COVID- 19. The aim being to try and capture these changes and ideas to ensure that these innovations are not lost when the NHS comes out of its pandemic measures.…

Read more of this article

Challenges and collaboration – progress for MSK in 2020

Alongside the pain and misery of the Covid-19 pandemic there have also been some beneficial side effects – quiet streets and skies, birdsong, less pollution. This is also true in the world of MSK. ARMA has been a champion for the NHS Change Challenge, a project to identify the new and innovative ways of working that have been rapidly developed across the NHS and to ensure beneficial changes are captured and locked in. I think it is no accident that NHS Improvement chose to pilot this in MSK.…

Read more of this article

Aspiring to Excellence programme 2020 open for applications

Following a successful start for the first cohort, applications are now open for the Aspiring to Excellence programme in 2020. The programme is designed to encourage and recognise service improvement in axial SpA (AS) care and is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB.

Whilst COVID19 is impacting on us all, NASS is keen to keep driving forward as much as possible and being practical with Aspiring to Excellence, and we welcome applications. The deadline for rheumatology teams to apply is 24 July 2020 and all the application details can be found on the NASS website.…

Read more of this article

COVID-19 / Coronavirus updates for Axial SpA patients

NASS is regularly updating their website with relevant COVID-19 information including how patients can assess their risk, medicines and biologic therapy, mental health and the effect of the virus on work and benefits.
www.nass.co.uk/covid19

Aspiring to Excellence programme 2020 open for applications

Following a successful start for the first cohort, applications are now open for the Aspiring to Excellence  programme in 2020. The programme is designed to encourage and recognise service improvement in axial SpA (AS) care and is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB.…

Read more of this article

ARMA roundtable on Pain

ARMA roundtable on Pain

In October 2019 ARMA held a roundtable bringing together people working on chronic pain from a range of perspectives to discuss what might be done to improve the experience of people living with chronic pain. Around 10–14% of people (6 – 8 million) experience moderate to severely disabling pain. Currently services and support for these people are difficult to access. Whilst not all chronic pain is musculoskeletal, osteoarthritis and back pain are associated with over half of all chronic pain, so that the lack of support is a key issue for us. …

Read more of this article

NHS extends testing of non-urgent care waiting times target changes

If you are referred for specialist non-urgent treatment, you currently should expect to be treated within a maximum waiting time of 18 weeks. Over the last year, the NHS has been reviewing this 18-week target. ARMA has been involved in the advisory group looking at this change.

The NHS England board meeting on 30 January announced plans to extend the testing period for proposed changes to the 18-week elective care measure into 2020/21.

This joint response was issued by National Voices, The Arthritis and Musculoskeletal Alliance, Versus Arthritis, the MS Society, the Neurological Alliance and Healthwatch England.…

Read more of this article

Guest blog: A Decade of Real Change

by Clare Jacklin, Chief Executive, NRAS

I heard a good joke during the Christmas break –

Question: What do you think next year will bring?
Answer: How would I know…? I don’t have 2020 vision!

Albert Einstein is widely credited with saying, “The definition of insanity is doing the same thing over and over again but expecting different results.”

Now, I’m not for a moment saying we’re all going insane but I wonder how many of you reading this feel (as I do) a sense of déjà vu that we’ve heard the same thing over and over but little change has occurred.…

Read more of this article